JP2019503979A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019503979A5 JP2019503979A5 JP2017562973A JP2017562973A JP2019503979A5 JP 2019503979 A5 JP2019503979 A5 JP 2019503979A5 JP 2017562973 A JP2017562973 A JP 2017562973A JP 2017562973 A JP2017562973 A JP 2017562973A JP 2019503979 A5 JP2019503979 A5 JP 2019503979A5
- Authority
- JP
- Japan
- Prior art keywords
- ligand
- conjugate
- linker
- alkyl
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022010563A JP2022068172A (ja) | 2015-11-25 | 2022-01-27 | ペプチド基を含む複合体及びそれに関連する方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562259997P | 2015-11-25 | 2015-11-25 | |
| US201562260006P | 2015-11-25 | 2015-11-25 | |
| US62/260,006 | 2015-11-25 | ||
| US62/259,997 | 2015-11-25 | ||
| PCT/IB2016/001810 WO2017089894A1 (en) | 2015-11-25 | 2016-11-23 | Conjugates comprising peptide groups and methods related thereto |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022010563A Division JP2022068172A (ja) | 2015-11-25 | 2022-01-27 | ペプチド基を含む複合体及びそれに関連する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019503979A JP2019503979A (ja) | 2019-02-14 |
| JP2019503979A5 true JP2019503979A5 (https=) | 2020-01-09 |
| JP7120765B2 JP7120765B2 (ja) | 2022-08-17 |
Family
ID=58763984
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017562973A Active JP7120765B2 (ja) | 2015-11-25 | 2016-11-23 | ペプチド基を含む複合体及びそれに関連する方法 |
| JP2022010563A Pending JP2022068172A (ja) | 2015-11-25 | 2022-01-27 | ペプチド基を含む複合体及びそれに関連する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022010563A Pending JP2022068172A (ja) | 2015-11-25 | 2022-01-27 | ペプチド基を含む複合体及びそれに関連する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11167040B2 (https=) |
| EP (1) | EP3380125A4 (https=) |
| JP (2) | JP7120765B2 (https=) |
| KR (1) | KR102847348B1 (https=) |
| CN (1) | CN108136038A (https=) |
| AU (1) | AU2016359234B2 (https=) |
| CA (1) | CA3006247A1 (https=) |
| TW (1) | TWI816638B (https=) |
| WO (1) | WO2017089894A1 (https=) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9480731B2 (en) * | 2013-12-12 | 2016-11-01 | Medy-Tox, Inc. | Long lasting effect of new botulinum toxin formulations |
| KR101628872B1 (ko) | 2014-05-28 | 2016-06-09 | 주식회사 레고켐 바이오사이언스 | 자가-희생 기를 포함하는 화합물 |
| WO2017051254A1 (en) * | 2015-09-25 | 2017-03-30 | Legochem Biosciences, Inc. | Compositions and methods related to anti-egfr antibody drug conjugates |
| WO2017051249A1 (en) | 2015-09-25 | 2017-03-30 | Legochem Biosciences, Inc. | Compositions and methods related to anti-cd19 antibody drug conjugates |
| WO2017083525A1 (en) | 2015-11-11 | 2017-05-18 | Opi Vi- Ip Holdco Llc | Composition and methods for anti-tnfr2 antibodies |
| KR102847350B1 (ko) * | 2015-11-25 | 2025-08-19 | 주식회사 리가켐바이오사이언스 | 분지된 링커를 포함하는 항체-약물 접합체 및 이의 제조방법 |
| HRP20240795T1 (hr) | 2015-11-25 | 2024-09-13 | Ligachem Biosciences Inc. | Konjugati koji se sastoje od samozapaljujućih skupina i postupci povezani s njima |
| AU2016359234B2 (en) | 2015-11-25 | 2022-09-08 | Ligachem Biosciences Inc. | Conjugates comprising peptide groups and methods related thereto |
| BR112019004935A2 (pt) | 2016-09-13 | 2019-06-04 | Allergan, Inc. | composições de toxina clostridial não proteíca estabilizada |
| MX2019011655A (es) | 2017-03-29 | 2019-12-19 | Legochem Biosciences Inc | Profarmaco de dimero de pirrolobenzodiazepina y compuesto conjugado ligando-conector de este. |
| CN118652192A (zh) | 2017-05-24 | 2024-09-17 | 德克萨斯州大学系统董事会 | 用于抗体药物缀合物的接头 |
| CN110314238A (zh) * | 2018-03-30 | 2019-10-11 | 烟台药物研究所 | 一种肿瘤靶向的多肽药物偶联物及其制备方法和应用 |
| JP7459063B2 (ja) | 2018-05-09 | 2024-04-01 | レゴケム バイオサイエンシズ， インク． | 抗－ｃｄ１９抗体薬物複合体に関連する組成物および方法 |
| KR102255487B1 (ko) | 2018-07-03 | 2021-07-21 | 주식회사 엘지에너지솔루션 | 배터리 모듈, 이러한 배터리 모듈을 포함하는 배터리 팩 및 이러한 배터리 팩을 포함하는 자동차 |
| GB201817321D0 (en) | 2018-10-24 | 2018-12-05 | Nanna Therapeutics Ltd | Microbeads for tagless encoded chemical library screening |
| JP2022530482A (ja) * | 2019-05-02 | 2022-06-29 | レゴケム バイオサイエンシズ， インク． | トリス構造を有するリンカーを含むリガンド―薬物複合体 |
| IL322315A (en) | 2019-05-14 | 2025-09-01 | Provention Bio Inc | Methods and preparations for preventing type 1 diabetes |
| CN112094321B (zh) * | 2019-06-18 | 2022-04-22 | 首都医科大学 | His-Gly-Glu修饰的甲氨蝶呤,其合成,抗转移活性和应用 |
| KR20210028544A (ko) | 2019-09-04 | 2021-03-12 | 주식회사 레고켐 바이오사이언스 | 인간 ror1에 대한 항체를 포함하는 항체 약물 접합체 및 이의 용도 |
| CN111007244B (zh) * | 2019-11-15 | 2021-10-08 | 中国农业科学院油料作物研究所 | 二乙酸镳草镰刀菌烯醇竞争型气压免疫传感器及检测方法 |
| WO2021137646A1 (ko) * | 2019-12-31 | 2021-07-08 | 주식회사 레고켐바이오사이언스 | 피롤로벤조디아제핀 유도체 및 이의 리간드-링커 접합체 |
| IL319200A (en) | 2020-04-16 | 2025-04-01 | Regeneron Pharma | Antibody-drug conjugates prepared using Diels-Alder compression methods |
| GB2594753B (en) * | 2020-05-27 | 2022-05-18 | Spirea Ltd | Antibody-drug conjugates |
| AU2021287998B2 (en) | 2020-06-11 | 2026-03-12 | Benaroya Research Institute At Virginia Mason | Methods and compositions for preventing type 1 diabetes |
| CN112679448B (zh) * | 2020-12-31 | 2022-08-19 | 苏州昊帆生物股份有限公司 | N-(2-氨基乙基)吗啉的制备方法 |
| EP4301782A1 (en) | 2021-03-05 | 2024-01-10 | Go Therapeutics, Inc. | Anti-glyco-cd44 antibodies and their uses |
| US12565529B2 (en) | 2021-05-24 | 2026-03-03 | Provention Bio, Inc. | Methods for treating type 1 diabetes |
| CN113636931B (zh) * | 2021-08-05 | 2024-02-13 | 康龙化成(宁波)科技发展有限公司 | 基因编码化合物库起始头片段化合物及其在基因编码化合物库合成上的应用 |
| JP2024531915A (ja) | 2021-08-05 | 2024-09-03 | ジーオー セラピューティクス，インコーポレイテッド | 抗グリコｍｕｃ抗体およびその使用 |
| WO2026080692A1 (en) * | 2024-10-09 | 2026-04-16 | Sutro Biopharma, Inc. | Branched beta-glucuronide linker-payloads, protein conjugates thereof, and methods thereof |
Family Cites Families (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5112739A (en) * | 1988-08-02 | 1992-05-12 | Polaroid Corporation | Enzyme controlled release system |
| DK0795334T3 (da) | 1996-03-12 | 2006-06-06 | Sanofi Aventis Deutschland | Nye prodrugs til behandling af tumorer og betændelsessygdomme |
| US6218519B1 (en) | 1996-04-12 | 2001-04-17 | Pro-Neuron, Inc. | Compounds and methods for the selective treatment of cancer and bacterial infections |
| US6759509B1 (en) | 1996-11-05 | 2004-07-06 | Bristol-Myers Squibb Company | Branched peptide linkers |
| JP2001505194A (ja) | 1996-11-05 | 2001-04-17 | ブリストル―マイヤーズ・スクイブ・カンパニー | 分枝ペプチド・リンカー |
| JP2006510626A (ja) | 2002-12-05 | 2006-03-30 | シエーリング アクチエンゲゼルシャフト | 増殖疾患の処理における部位特異的供給のためのエポチロン類似体 |
| US7498298B2 (en) | 2003-11-06 | 2009-03-03 | Seattle Genetics, Inc. | Monomethylvaline compounds capable of conjugation to ligands |
| PE20100251A1 (es) | 2004-09-10 | 2010-04-10 | Wyeth Corp | Anticuerpos anti-5t4 humanizados y conjugados anticuerpo anti-5t4/calicheamicina |
| HUE035853T2 (en) * | 2005-07-18 | 2018-05-28 | Seattle Genetics Inc | Beta-glucuronide-linker-drug conjugates |
| JP2010503706A (ja) | 2006-09-15 | 2010-02-04 | エンゾン ファーマスーティカルズ インコーポレイテッド | リジン系ポリマーリンカー |
| CN103073641B (zh) | 2006-11-10 | 2015-01-21 | 株式会社立富泰克 | 在体内具有抗肿瘤活性的抗人Dlk-1抗体 |
| CL2007003622A1 (es) | 2006-12-13 | 2009-08-07 | Medarex Inc | Anticuerpo monoclonal humano anti-cd19; composicion que lo comprende; y metodo de inhibicion del crecimiento de celulas tumorales. |
| WO2009016647A1 (en) | 2007-08-01 | 2009-02-05 | Council Of Scientific & Industrial Research | Pyrrolo [2,1-c][1, 4] benzodiazepine-glycoside prodrugs useful as a selective anti tumor agent |
| WO2010124188A1 (en) | 2009-04-23 | 2010-10-28 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-human ror1 antibodies |
| US9353140B2 (en) | 2009-11-25 | 2016-05-31 | Academia Sinica | BQC-G, a tumor-selective anti-cancer prodrug |
| FR2960153B1 (fr) | 2010-05-20 | 2012-08-17 | Centre Nat Rech Scient | Nouveaux bras autoreactifs et prodrogues les comprenant |
| US9591882B2 (en) | 2010-08-05 | 2017-03-14 | Robert LaGrand Duffin | Absorbent sleeve |
| EP3828205A1 (en) | 2010-10-01 | 2021-06-02 | Oxford BioTherapeutics Ltd | Anti-ror1 antibodies |
| KR20120107741A (ko) | 2011-03-22 | 2012-10-04 | 한국생명공학연구원 | 패혈증 단백질 치료제의 효능 분석 및 스크리닝 방법 |
| KR101438265B1 (ko) | 2011-04-04 | 2014-09-05 | 한국생명공학연구원 | Ｄｌｋ１ 특이적 인간 항체 및 이를 포함하는 약학적 조성물 |
| WO2012148427A1 (en) | 2011-04-29 | 2012-11-01 | Hewlett-Packard Development Company, L.P. | Systems and methods for in-memory processing of events |
| HUE045348T2 (hu) | 2011-05-08 | 2019-12-30 | Legochem Biosciences Inc | Fehérje-hatóanyag konjugátumok és eljárás elõállításukra |
| ES2945932T3 (es) | 2011-10-14 | 2023-07-10 | Seagen Inc | Pirrolobenzodiazepinas y conjugados dirigidos |
| JP6228551B2 (ja) * | 2012-01-03 | 2017-11-08 | インビクタス オンコロジー プライベート リミテッド | リガンド−標的指向分子およびその方法 |
| CN105189507A (zh) | 2012-12-21 | 2015-12-23 | 斯皮罗根有限公司 | 吡咯并苯并二氮杂卓及其结合物 |
| KR20220041957A (ko) | 2013-03-15 | 2022-04-01 | 아비에 도이치란트 게엠베하 운트 콤파니 카게 | 항-egfr 항체 약물 접합체 제형 |
| WO2014194030A2 (en) * | 2013-05-31 | 2014-12-04 | Immunogen, Inc. | Conjugates comprising cell-binding agents and cytotoxic agents |
| WO2015052533A1 (en) | 2013-10-11 | 2015-04-16 | Spirogen Sàrl | Pyrrolobenzodiazepine-antibody conjugates |
| ES2826398T3 (es) * | 2013-10-15 | 2021-05-18 | Seagen Inc | Enlazadores-fármacos pegilados para una mejor farmacocinética de los conjugados ligando-fármaco |
| JP6701077B2 (ja) | 2013-12-19 | 2020-05-27 | シアトル ジェネティックス， インコーポレイテッド | 標的化薬物結合体と使用するためのメチレンカルバメートリンカー |
| EP2913064A1 (en) | 2014-02-26 | 2015-09-02 | celares GmbH | Branched drug-linker conjugates for the coupling to biological targeting molecules |
| KR101628872B1 (ko) | 2014-05-28 | 2016-06-09 | 주식회사 레고켐 바이오사이언스 | 자가-희생 기를 포함하는 화합물 |
| TWI805109B (zh) | 2014-08-28 | 2023-06-11 | 美商奇諾治療有限公司 | 對cd19具專一性之抗體及嵌合抗原受體 |
| SI3900742T1 (sl) | 2014-09-11 | 2024-10-30 | Seagen Inc. | Ciljana dostava zdravilnih snovi, ki vsebujejo terciarne amine |
| BR112017012342A2 (pt) | 2014-12-09 | 2018-02-27 | Abbvie Inc | compostos inibitórios de bcl-xl e conjugados de anticorpo-fármaco incluindo os mesmos |
| KR20160080832A (ko) | 2014-12-29 | 2016-07-08 | 주식회사 레고켐 바이오사이언스 | 리피바디 유도체-약물 복합체, 그 제조방법 및 용도 |
| JP6865688B2 (ja) | 2015-01-16 | 2021-04-28 | ジュノー セラピューティクス インコーポレイテッド | Ｒｏｒ１に特異的な抗体およびキメラ抗原受容体 |
| HUE055644T2 (hu) | 2015-01-30 | 2022-03-28 | Sutro Biopharma Inc | Hemiasterlin származékok konjugációra és terápiára |
| WO2017051254A1 (en) | 2015-09-25 | 2017-03-30 | Legochem Biosciences, Inc. | Compositions and methods related to anti-egfr antibody drug conjugates |
| WO2017051249A1 (en) | 2015-09-25 | 2017-03-30 | Legochem Biosciences, Inc. | Compositions and methods related to anti-cd19 antibody drug conjugates |
| IL299203A (en) | 2015-10-13 | 2023-02-01 | Eureka Therapeutics Inc ׂ A Delaware Corp | Antibody factors specific for human differentiation group 19 and their uses |
| KR102847350B1 (ko) | 2015-11-25 | 2025-08-19 | 주식회사 리가켐바이오사이언스 | 분지된 링커를 포함하는 항체-약물 접합체 및 이의 제조방법 |
| AU2016359234B2 (en) | 2015-11-25 | 2022-09-08 | Ligachem Biosciences Inc. | Conjugates comprising peptide groups and methods related thereto |
| HRP20240795T1 (hr) | 2015-11-25 | 2024-09-13 | Ligachem Biosciences Inc. | Konjugati koji se sastoje od samozapaljujućih skupina i postupci povezani s njima |
| GB201617466D0 (en) | 2016-10-14 | 2016-11-30 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
| EP3535299A1 (en) | 2016-11-04 | 2019-09-11 | Novimmune S.A. | Anti-cd19 antibodies and methods of use thereof |
| MX2019011655A (es) | 2017-03-29 | 2019-12-19 | Legochem Biosciences Inc | Profarmaco de dimero de pirrolobenzodiazepina y compuesto conjugado ligando-conector de este. |
| MX2019015057A (es) | 2017-06-23 | 2020-08-03 | Velosbio Inc | Inmunoconjugados de anticuerpos receptor huérfano similar al receptor tirosina cinasa 1 (ror1). |
| KR20190018400A (ko) | 2017-08-14 | 2019-02-22 | 주식회사 레고켐 바이오사이언스 | EGFRvIII에 대한 항체를 포함하는 항체 약물 접합체 |
| KR102125032B1 (ko) | 2017-09-08 | 2020-06-19 | 주식회사 와이바이오로직스 | 인간 dlk1에 대한 항체 및 이의 용도 |
| JP7459063B2 (ja) | 2018-05-09 | 2024-04-01 | レゴケム バイオサイエンシズ， インク． | 抗－ｃｄ１９抗体薬物複合体に関連する組成物および方法 |
| WO2019225777A1 (ko) | 2018-05-23 | 2019-11-28 | 에이비엘바이오 주식회사 | 항-ror1 항체 및 그 용도 |
| EP3936150A4 (en) | 2019-03-06 | 2023-03-29 | LegoChem Biosciences, Inc. | ANTIBODY-DRUG CONJUGATES COMPRISING ANTIBODY AGAINST HUMAN DLK1 AND USE THEREOF |
-
2016
- 2016-11-23 AU AU2016359234A patent/AU2016359234B2/en active Active
- 2016-11-23 US US15/779,450 patent/US11167040B2/en active Active
- 2016-11-23 KR KR1020187018067A patent/KR102847348B1/ko active Active
- 2016-11-23 CN CN201680030739.4A patent/CN108136038A/zh active Pending
- 2016-11-23 JP JP2017562973A patent/JP7120765B2/ja active Active
- 2016-11-23 WO PCT/IB2016/001810 patent/WO2017089894A1/en not_active Ceased
- 2016-11-23 CA CA3006247A patent/CA3006247A1/en active Pending
- 2016-11-23 EP EP16868095.7A patent/EP3380125A4/en active Pending
- 2016-11-25 TW TW105138779A patent/TWI816638B/zh active
-
2022
- 2022-01-27 JP JP2022010563A patent/JP2022068172A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019503979A5 (https=) | ||
| JP2019503981A5 (https=) | ||
| JP2019503980A5 (https=) | ||
| HRP20240795T1 (hr) | Konjugati koji se sastoje od samozapaljujućih skupina i postupci povezani s njima | |
| KR101921068B1 (ko) | 단백질-활성제 접합체 및 이의 제조 방법 | |
| US10036010B2 (en) | Recognition tags for TGase-mediated conjugation | |
| KR102847350B1 (ko) | 분지된 링커를 포함하는 항체-약물 접합체 및 이의 제조방법 | |
| KR102847348B1 (ko) | 펩타이드 그룹을 포함하는 접합체 및 이와 관련된 제조방법 | |
| JP2023100863A (ja) | 抗体薬物複合体及びその応用 | |
| JP2021113210A (ja) | 抱合方法 | |
| JP2021523232A5 (https=) | ||
| JP7256751B2 (ja) | β－ガラクトシドが導入された自己犠牲リンカーを含む化合物 | |
| JPS61227532A (ja) | 抗体ハイブリツド分子およびその製造方法 | |
| JPWO2019215510A5 (https=) | ||
| JP2024160336A (ja) | トリス構造を有するリンカーを含むリガンド―薬物複合体 | |
| US20240261425A1 (en) | Conjugate and the preparing method and use thereof | |
| JPWO2020180121A5 (https=) | ||
| WO2024078612A1 (en) | Linker-payload compound, conjugates and applications thereof | |
| JPWO2022211508A5 (https=) | ||
| KR102501394B1 (ko) | 트리스 구조를 가지는 링커를 포함하는 리간드-약물 접합체 | |
| RU2021128538A (ru) | Коньюгаты антитело-лекарственное средство, включающие антитело против человеческого dlk1, и их применение | |
| KR20250163875A (ko) | 핵 위치화 폴리펩타이드 및 컨주게이트 및 이의 용도 | |
| RU2025127084A (ru) | Конъюгат антитело-лекарственное средство, содержащий антитела против l1cam человека, и его применение | |
| RU2020140202A (ru) | Композиции и способы, относящиеся к конъюгатам лекарственных средств с антителами против cd19 | |
| HK1190330A (en) | Protein-active agent conjugates and method for preparing the same |